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Abstract
Objective-Detailed analysis of primary cutaneous melanoma first diagnosed in Scotland in patients aged 65 and over.
Design-Comparison of changing incidence, sex distribution, site, histogenetic type, tumour thickness, and prognosis of all primary cutaneous melanomas in patients aged 65 and over diagnosed in Scotland in the 11 years 1979-89 with similar data for patients aged under 65. Setting-Data were obtained from the Scottish Melanoma Group's database, established in 1979, which aims to record detailed clinical, pathological, and surgical foliow up details ofall primary cutaneous melanomas registered in Scotland.
Patients-1430 patients (954 women, 476 men) aged 65 and over; comprising over a third of the 3903 patients with primary melanoma recorded for all age groups in Scotland during this period.
Results-The overall incidence of melanoma in patients aged 65 and over increased from 12*2/100 000 in 1979 to 20*7/100 000 in 1989, with the greatest increase seen in older men, from 7 8/100 000 in 1979 to 18-0/100000 in 1989. The site most commonly affected was the face in both men and women (33% of all tumours). The most common histogenetic type was superficial spreading melanoma. 526 patients (37%) had melanomas with a tumour thickness of 3 5 mm or greater in the older age group, compared with 453 patients (18%) in those aged under 65 . The highest proportion of thick tumours was seen in older men. Five year survival figures for
Introduction
The incidence of cutaneous melanoma is rising steadily. Melanoma is a solid tumour that can affect all age groups, and the median age world wide at presentation is 48 years. The most important prognostic factor in primary melanoma is the tumour thickness as measured microscopically from the granular layer of the overlying epidermis to the deepest underlying malignant melanoma cell.2 Recently several public education exercises have been aimed at secondary prevention of melanoma, particularly in younger people. Our impression in our pigmented lesion clinic in the west of Scotland was that younger members of the public were becoming better informed about melanoma and seeking advice earlier about thinner tumours, leading in turn to a better prognosis, but in the over 65s many patients were still not aware of the signs of early melanoma. We also had the impression that older patients were not seeking medical treatment until their melanomas were relatively thick.
A current concept of melanoma in elderly people is that it is mainly of the lentigo maligna melanoma type, and is a slowly growing non-aggressive tumour. This image was inconsistent with our own experience. For Trends over time were estimated by deriving the best fit linear regression of incidence against year. Probability values were derived from the significance of the steepness of the gradient of the regression equation.
The percentages oftumours with a Breslow thickness of 1 5 mm or greater before and after the introduction of the public education campaign were compared using a logistic regression model.3 This allowed adjustment to be made for variations in age, site, and histogenetic type over the period of the study.
The percentage of patients surviving five years was estimated by using life table techniques4 both for mortality from all causes and for deaths considered to be tumour related.
Results
In the period 1979-89, 1430 patients (954 women and 476 men) aged 65 years or over were registered in Scotland with primary cutaneous melanoma (table I) , comprising over a third (37%) of the 3903 primary melanomas recorded for all age groups in Scotland during this period. This represents an overall increase in age and sex adjusted incidence from 12 2/100 000 in 1979 to 20 7/100 000 in 1989 in those patients aged 65 and over. Figure 1 illustrates the increase in all age groups. The greatest increase, 131%, is seen in older men, in whom over the 11 year period the incidence increased from 7 8/100 000 to 18 0/100 000.
In series looking at all age groups, the most common site of melanoma is the leg in women and the trunk in men. In our patients aged 65 and over, however, the face was the most common site in both men and women ( tumours. The trunk was the second most common site in older men; in older women it was the leg. Acral, mucosal, and subungual melanomas were also more common in the older age group. In most published series of all age groups the commonest reported histogenetic type is superficial spreading melanoma, usually accounting for 60-70% of lesions. Nodular melanomas usually account for 15-20%, lentigo maligna melanoma for 5-10%, and acral or mucosal lesions for 2-5%. Table III shows that in this series of patients aged 65 and over superficial spreading melanoma was also the most common histogenetic type (34% of melanomas), although the proportion was lower than in general series, while the proportion of other histogenetic types was increased. In the older age group nodular melanomas comprised 26%, lentigo maligna melanomas 25%, and acral or mucosal lesions 9%. The steadily increasing incidence of melanoma over the decade of study was associated with a large increase in superficial spreading melanomas in older women and a significant increase in superficial spreading melanoma, lentigo maligna melanoma, and nodular types in older men (fig 2) . No significant increase in the incidence of acral or mucosal tumours was seen for either men or women over the period of study.
Tumour thickness measurement showed that 526 (37%) patients aged 65 and over had melanomas that were 3 5 mm or thicker during the 11 year period. Of these, 169 (32%) were found in the head and neck area (table IV) . Thus over a third of melanomas in the older age group occurred in the head and neck region, and of these about a third fell into the worst thickness category.
The most important factor in prognosis for melanoma is tumour thickness. We looked at the proportion of melanomas with Breslow thicknesses of 1-5 mm or greater before and after the public education campaigns (table V). In both men and women under 65 there was a significant fall in the proportion of tumours I 1 5 mm (p<0001). In men aged 65 and over the fall in the proportion of these tumours was not significant. BMJ VOLUME 304 mm, 1-5-3-49 mm, and -3-5 mm were 88%, 66%, and 47% respectively. In each thickness group survival was better for women than for men. Overall, the five year survival specific for melanoma was 64% for the older age group, which is similar to the survival rate reported by other groups for older patients. directed not only at elderly people but also at those who care for them. Campaigns should emphasise that in older people the incidence of melanoma is increasing, particularly in older men; the site most commonly affected in both sexes is the face; and if melanoma is identified early the outlook is still good.
Changing patterns of delivery of health care in the United Kingdom, with greater emphasis on health education and prevention in general practice, mean that this could be an appropriate time to enlist the help of family doctors in a specific programme aimed at informing elderly people about the features of early cutaneous melanoma. This will entail dermatologists offering a preparatory educational programme to general practitioners to help them differentiate true early melanoma from benign non-melanoma pigmented lesions. This programme should also be aimed at district nurses and others involved in the care of elderly patients.
Home based care and standard hospital care for patients with severe mental illness: a randomised controlled trial Conclusions-Home based care may offer some slight advantages over hospital based care for patients with serious mental illness and their relatives. The care is intensive, but the low drop out rate suggests appreciation. Changes to traditional training for mental health workers are required.
Introduction
For about 40 years in most Western countries there has been a steady move away from treating patients with a serious mental illness in mental hospitals to caring for them in the community.' 2 In Britain this trend has been bolstered by official policy.34 Initially, little research evidence was produced to support the advantages of community care, but in the past two decades several controlled studies outside Britain have compared home and inpatient care.56 The outcome measures used in the studies varied, but any significant differences consistently favoured the patients cared for at home with greater improvement in clinical symptoms and social functioning and in patients' and relatives' satisfaction. No study found inpatient care to be better on any variable.5 At the end of the studies the patients cared for at home still had many symptoms and much disability despite their relatively greater improvement. 
